Organisation Of Pharmaceutical Producers Of India

Rediff.com » News » Organisation Of Pharmaceutical Producers Of India

News for Organisation Of Pharmaceutical Producers Of India

News
Business

Govt cuts customs duty on 3 cancer drugs

The government on Tuesday proposed to fully exempt three cancer medicines from customs duties. The government proposes to cut customs duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab......

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......

AstraZeneca's COVID-19 Vaccine: The TTS Factor

'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters The controversial......

World Bank report warns of heatwaves beyond endurance in India

Severe heatwaves, responsible for thousands of deaths across India over the last few decades, are increasing with alarming frequency and soon the country could become one of the first places in the......

'Pharma cos face probs in distribution of drugs in J-K'

Pharmaceutical companies, which are sending across medical aid for flood affected people in Jammu and Kashmir, claim to be facing difficulties in distribution of drugs M Srinivas Reddy, director......

Budget 2024: Wishlist of the pharma industry

There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical......

GST waiver for rare disease drugs brings little relief: pharma sector

India’s pharma sector on Wednesday said the Goods and Services Tax (GST) Council’s decision to exempt tax on rare diseases drugs is unlikely to benefit the population unless the waiver......

Budget 2023: What the pharma, healthcare industry seek

The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Illustration:......

Key mantra for India's pharma sector in 2023

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......

After 15 years, Ranjit Shahani steps down as Novartis' India chief

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in......

Rediff News

Organisation Of Pharmaceutical Producers Of India

News for Organisation Of Pharmaceutical Producers Of India

Govt cuts customs duty on 3 cancer drugs

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

AstraZeneca's COVID-19 Vaccine: The TTS Factor

World Bank report warns of heatwaves beyond endurance in India

'Pharma cos face probs in distribution of drugs in J-K'

Budget 2024: Wishlist of the pharma industry

GST waiver for rare disease drugs brings little relief: pharma sector

Budget 2023: What the pharma, healthcare industry seek

Key mantra for India's pharma sector in 2023

After 15 years, Ranjit Shahani steps down as Novartis' India chief

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS